Skip to main content
ARLO
NYSE Trade & Services

Arlo Technologies Reports Record Q1 2026 Results with Strong Profitability, Subscription Growth, and Positive Outlook

Analysis by Arik Shkolnikov
Sentiment info
Positive
Importance info
8
Price
$16.3
Mkt Cap
$1.623B
52W Low
$10.2
52W High
$19.94
Market data snapshot near publication time

summarizeSummary

Arlo Technologies reported record Q1 2026 financial results, including a return to net profitability, significant revenue and subscription growth, and expanded gross margins, alongside strategic acquisitions and a stock repurchase program.


check_boxKey Events

  • Record Q1 Financial Performance

    Reported record total revenue of $150.4 million, GAAP net income of $15 million (vs. a loss year-over-year), and record non-GAAP EPS of $0.28. GAAP gross margin reached a record 48.3%, up 400 basis points year-over-year.

  • Strong Subscription and Recurring Revenue Growth

    Subscriptions and services revenue grew 30.9% year-over-year to a record $90.1 million, accounting for 59.9% of total revenue. Annual Recurring Revenue (ARR) increased 29.2% to $357 million, and cumulative paid accounts surpassed 6 million.

  • Strategic Initiatives and Capital Allocation

    Completed the acquisition of Aloe Care Health to expand AI-powered aging-in-place services. Repurchased $8.0 million of common stock as part of a $50 million authorized program and recorded a $6.4 million gain from the sale of a strategic investment.

  • Positive Q2 2026 Outlook

    Provided a strong outlook for the second quarter of 2026, projecting revenue between $145 million and $155 million, and non-GAAP EPS between $0.17 and $0.23.


auto_awesomeAnalysis

Arlo Technologies delivered exceptionally strong first-quarter 2026 results, marking a significant return to net profitability and demonstrating robust growth across key financial and operational metrics. The company achieved record revenue, gross margins, and EPS, driven by substantial growth in its high-margin subscriptions and services segment. Strategic initiatives, including the acquisition of Aloe Care Health and an ongoing stock repurchase program, further underscore management's confidence and commitment to expanding market opportunities and returning value to shareholders. The positive outlook for Q2 2026 suggests continued momentum. This 8-K, which includes the detailed press release, provides the full context for the strong Q1 performance previously summarized in concurrent news alerts and a 10-Q filing.

At the time of this filing, ARLO was trading at $16.30 on NYSE in the Trade & Services sector, with a market capitalization of approximately $1.6B. The 52-week trading range was $10.20 to $19.94. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed ARLO - Latest Insights

ARLO
May 07, 2026, 4:22 PM EDT
Filing Type: 10-Q
Importance Score:
8
ARLO
May 07, 2026, 4:13 PM EDT
Source: Wiseek News
Importance Score:
9
ARLO
May 07, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
8
ARLO
Apr 16, 2026, 4:01 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
ARLO
Apr 07, 2026, 6:01 AM EDT
Filing Type: 8-K
Importance Score:
7
ARLO
Feb 26, 2026, 9:47 PM EST
Filing Type: 10-K
Importance Score:
8
ARLO
Feb 26, 2026, 4:50 PM EST
Filing Type: 8-K
Importance Score:
8